Enlivex
ENLV • NASDAQ
Enlivex is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Oren Hershkovitz, with a market cap of $250.1M.
CEOOren Hershkovitz
Next Earnings
Upcoming earnings announcement for Enlivex
Date
Friday, May 29, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.01
Earnings History
Past 12 earnings reports for Enlivex
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$0.20Est: -$0.03 | -566.7% | - | — | — |
| Apr 30, 2025 | Q4 2024 | —Est: -$0.16 | — | — | — | — |
| Nov 29, 2024 | Q3 2024 | -$0.12 | — | - | — | — |
| Aug 30, 2024 | Q2 2024 | -$0.16Est: -$0.15 | -6.7% | - | — | — |
| Jun 14, 2024 | Q1 2024 | -$0.22Est: -$0.18 | -22.2% | - | — | — |
| Mar 29, 2024 | Q4 2023 | -$0.48Est: -$0.28 | -71.4% | - | — | — |
| Nov 9, 2023 | Q3 2023 | -$0.32Est: -$0.39 | +17.9% | - | — | — |
| Sep 1, 2023 | Q2 2023 | -$0.37Est: -$0.46 | +19.6% | - | — | — |
| Jun 16, 2023 | Q1 2023 | -$0.39 | — | - | — | — |
| Apr 10, 2023 | Q4 2022 | -$0.39Est: -$0.34 | -14.7% | - | — | — |
| Dec 2, 2022 | Q3 2022 | -$0.31 | — | - | — | — |
| Aug 22, 2022 | Q2 2022 | -$0.54 | — | - | — | — |